Eric Marandett and Irina Oberman Khagi on the Ariosa Decision

Intellectual Property Law360

 | November 3, 2015

 | Eric Marandett and Irina Oberman Khagi

View "Ariosa V. Sequenom Signals Trouble Ahead For Life Sciences"

Eric Marandett and Irina Oberman Khagi wrote "Ariosa V. Sequenom Signals Trouble Ahead For Life Sciences," in Intellectual Property Law360 where they discuss the Federal Circuit's recent decision in the Ariosa case.  They explain that the decision can potentially place at risk patents directed to diagnostic methods, vaccine technology, gene therapy and personalized medicine techniques that have been the subject of significant research and development investment in recent years.  The article also appeared in Life Sciences Law360 and Appellate Law360.

 

Thank you for reaching out to contact Choate. Before you send your message, we wanted to make sure you are aware of the following. Please do not send any confidential information in response to this link. Sending an e-mail to Choate does not give rise to an attorney-client relationship, and will not be deemed to disqualify Choate from undertaking any engagement for a current or future client.  Before any attorney-client engagement may be formed, Choate will need to check for possible conflicts of interest, you will need to consider whether you wish to retain Choate as counsel, and we will need to consider whether we wish to accept the potential engagement. In the meantime, Choate reserves the right to represent parties with interests adverse to you.

AcceptDecline